No Cases of Nephrogenic Systemic Fibrosis after Administration of Gadoxetic Acid-Reference-Cited by-同舟云学术

No Cases of Nephrogenic Systemic Fibrosis after Administration of Gadoxetic Acid

Published:2020-12 Issue:3 Volume:297 Page:556-562
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Starekova Jitka¹^ORCID,Bruce Richard J.¹^ORCID,Sadowski Elizabeth A.¹^ORCID,Reeder Scott B.¹^ORCID

Affiliation:

1. From the Departments of Radiology (J.S., R.J.B., E.A.S., S.B.R.), Obstetrics and Gynecology (E.A.S.), Medical Physics (S.B.R.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), and Emergency Medicine (S.B.R.), University of Wisconsin, 600 Highland Ave, Madison, WI 53792.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2020200788

Reference31 articles.

1. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions

2. The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a review

3. Primovist, Eovist: What to expect?

4. Safety of gadoxetate disodium: Results from the clinical phase II–III development program and postmarketing surveillance

5. Half-dose gadoxetic acid-enhanced liver magnetic resonance imaging in patients at risk for nephrogenic systemic fibrosis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI contrast agents and retention in the brain: review of contemporary knowledge and recommendations to the future;Insights into Imaging;2024-07-25

2. MR Angiography of Pulmonary Vasculature;Magnetic Resonance Imaging Clinics of North America;2023-08

3. Gadolinium-Based Contrast Agent Safety with Focus on Kidney MRI;Advanced Clinical MRI of the Kidney;2023

4. Abbreviated MRI with second shot arterial phase for HCC evaluation: modified version of LI-RADS and recall reduction strategy;European Radiology;2022-12-23

5. Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use;Texas Heart Institute Journal;2022-05-01